193 related articles for article (PubMed ID: 18082037)
21. Infections in a surgical intensive care unit of a university hospital in Greece.
Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S
Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
[TBL] [Abstract][Full Text] [Related]
23. [Investigation of nosocomial infection in the neonatal intensive care unit].
Cai XD; Cao Y; Chen C; Yang Y; Wang CQ; Zhang L; Ding H
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Feb; 12(2):81-4. PubMed ID: 20199716
[TBL] [Abstract][Full Text] [Related]
24. Early- and late-onset ventilator-associated pneumonia acquired in the intensive care unit: comparison of risk factors.
Giard M; Lepape A; Allaouchiche B; Guerin C; Lehot JJ; Robert MO; Fournier G; Jacques D; Chassard D; Gueugniaud PY; Artru F; Petit P; Robert D; Mohammedi I; Girard R; Cêtre JC; Nicolle MC; Grando J; Fabry J; Vanhems P
J Crit Care; 2008 Mar; 23(1):27-33. PubMed ID: 18359418
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy.
Gursel G; Aydogdu M; Ozyilmaz E; Ozis TN
J Crit Care; 2008 Mar; 23(1):34-40. PubMed ID: 18359419
[TBL] [Abstract][Full Text] [Related]
27. The microbiology of ventilator-associated pneumonia.
Park DR
Respir Care; 2005 Jun; 50(6):742-63; discussion 763-5. PubMed ID: 15913466
[TBL] [Abstract][Full Text] [Related]
28. [Nosocomial ventilator-associated pneumonia in a tropical intensive care unit].
Diouf E; Beye MD; Diop Ndoye M; Kane O; Seydi AA; Ndiaye PI; Bah MD; Sall KB
Dakar Med; 2006; 51(2):81-8. PubMed ID: 17632982
[TBL] [Abstract][Full Text] [Related]
29. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of the risk factors of pulmonary fungal infections related to mechanical ventilation and prognosis of the patients].
Li M; Chen ZG; Zhang CR; Lin JC; Zeng M
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):463-6. PubMed ID: 18359715
[TBL] [Abstract][Full Text] [Related]
31. Ventilator-associated pneumonia in a paediatric intensive care unit in a developing country with high HIV prevalence.
Morrow BM; Argent AC
J Paediatr Child Health; 2009 Mar; 45(3):104-11. PubMed ID: 19210603
[TBL] [Abstract][Full Text] [Related]
32. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
33. [Pulmonary infections in preterm newborns].
Vendettuoli V; De Cunto A; Tana M; Tirone C; Boccacci S; Vento G; Romagnoli C
Minerva Pediatr; 2007 Apr; 59(2):97-105. PubMed ID: 17404559
[TBL] [Abstract][Full Text] [Related]
34. The impact of ventilator-associated pneumonia on the Canadian health care system.
Muscedere JG; Martin CM; Heyland DK
J Crit Care; 2008 Mar; 23(1):5-10. PubMed ID: 18359415
[TBL] [Abstract][Full Text] [Related]
35. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia.
Mueller EW; Croce MA; Boucher BA; Hanes SD; Wood GC; Swanson JM; Chennault SK; Fabian TC
J Trauma; 2007 Dec; 63(6):1329-37; discussion 1337. PubMed ID: 18212657
[TBL] [Abstract][Full Text] [Related]
36. Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial.
Shorr AF; Cook D; Jiang X; Muscedere J; Heyland D;
J Crit Care; 2008 Mar; 23(1):64-73. PubMed ID: 18359423
[TBL] [Abstract][Full Text] [Related]
37. [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].
Fekih Hassen M; Ayed S; Ben Sik Ali H; Gharbi R; Marghli S; Elatrous S
Ann Fr Anesth Reanim; 2009 Jan; 28(1):16-23. PubMed ID: 19097848
[TBL] [Abstract][Full Text] [Related]
38. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.
Korbila IP; Michalopoulos A; Rafailidis PI; Nikita D; Samonis G; Falagas ME
Clin Microbiol Infect; 2010 Aug; 16(8):1230-6. PubMed ID: 19732088
[TBL] [Abstract][Full Text] [Related]
39. Risk factors and pathogen profile of ventilator-associated pneumonia in a neonatal intensive care unit in China.
Deng C; Li X; Zou Y; Wang J; Wang J; Namba F; Hiroyuki Y; Yu J; Yamauchi Y; Guo C
Pediatr Int; 2011 Jun; 53(3):332-7. PubMed ID: 21496177
[TBL] [Abstract][Full Text] [Related]
40. Strategies in the prevention and management of ventilator-associated pneumonia.
Pieracci FM; Barie PS
Am Surg; 2007 May; 73(5):419-32. PubMed ID: 17520992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
